Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial

The Lancet Oncology- United Kingdom

doi 10.1016/s1470-2045(12)70414-x

Full Text

Abstract

Available in

Categories

Date

December 1, 2012

Authors

Kent A Robertson

Grzegorz Nalepa

Daniel C Bowers

Gary D Hutchins

Cynthia M Hingtgen

Laurence E Walsh

Kamnesh R Pradhan

Mary K Edwards-Brown

James W Fletcher

Jeffrey B Travers

Marcie R Sherman

Cynthia J Davis

Publisher

Elsevier BV

Related search

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

English

Multiple Plexiform Neurofibromas in Neurofibromatosis Type 1: A Case Report

Journal of Medical Science And clinical Research

Breton

Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1

Archives of Otolaryngology–Head & Neck Surgery

English

Phase I Clinical Trial Combining Imatinib Mesylate and IL-2

English

Hypervascular Neurofibromas in a Case of Neurofibromatosis Type 1 - A Case Report

Journal of Clinical and Experimental Dentistry

English

554 Sirolimus Gel Effectively Reduced Neurofibromas in Neurofibromatosis Type 1 in a Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of Investigative Dermatology

Molecular Biology

English

Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients With Neurofibromatosis Type 1

American Journal of Human Genetics

English

Giant Plexiform Neurofibroma Causing Asymptomatic Cervical Spinal Cord Compression in a Child With Neurofibromatosis Type 1

BMJ Case Reports

English

Craniofacial Plexiform Neurofibromatosis

Journal of Contemporary Dentistry

English